{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T12:02:24Z","timestamp":1771761744841,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,22]]},"DOI":"10.7759\/cureus.104053","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:29:13Z","timestamp":1771759753000},"source":"Crossref","is-referenced-by-count":0,"title":["Papillary Thyroid Carcinoma in a Patient With a Germline Titin (TTN) Mutation"],"prefix":"10.7759","author":[{"given":"Summiya","family":"Nasim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman DS","year":"2012","unstructured":"Herman DS, Lam L, Taylor MR, et al.. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012, 366:619-28. 10.1056\/NEJMoa1110186","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12741","article-title":"Relevance of truncating titin mutations in dilated cardiomyopathy","volume":"90","author":"Akinrinade O","year":"2016","unstructured":"Akinrinade O, Alastalo TP, Koskenvuo JW. Relevance of truncating titin mutations in dilated cardiomyopathy. Clin Genet. 2016, 90:49-54. 10.1111\/cge.12741","journal-title":"Clin Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-019-0107-6","article-title":"Spontaneous mutations in the single TTN gene represent high tumor mutation burden","volume":"5","author":"Oh JH","year":"2020","unstructured":"Oh JH, Jang SJ, Kim J, et al.. Spontaneous mutations in the single TTN gene represent high tumor mutation burden. NPJ Genom Med. 2020, 5:33. 10.1038\/s41525-019-0107-6","journal-title":"NPJ Genom Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov LB","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, et al.. The repertoire of mutational signatures in human cancer. Nature. 2020, 578:94-101. 10.1038\/s41586-020-1943-3","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20221168","article-title":"TTN mutations predict a poor prognosis in patients with thyroid cancer","volume":"42","author":"Han X","year":"2022","unstructured":"Han X, Chen J, Wang J, Xu J, Liu Y. TTN mutations predict a poor prognosis in patients with thyroid cancer. Biosci Rep. 2022, 42:BSR20221168. 10.1042\/BSR20221168","journal-title":"Biosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing M","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013, 13:184-99. 10.1038\/nrc3431","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/187153009789044338","article-title":"Genetic alterations in differentiated thyroid cancers","volume":"9","author":"Salehian B","year":"2009","unstructured":"Salehian B, Liu Z. Genetic alterations in differentiated thyroid cancers. Endocr Metab Immune Disord Drug Targets. 2009, 9:257-68. 10.2174\/187153009789044338","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas ES","year":"2017","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017, 27:1341-6. 10.1089\/thy.2017.0500","journal-title":"Thyroid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel KN","year":"2018","unstructured":"Patel KN, Angell TE, Babiarz J, et al.. Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surg. 2018, 153:817-24. 10.1001\/jamasurg.2018.1153","journal-title":"JAMA Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2021.07.002","article-title":"Performance of Afirma gene sequencing classifier versus gene expression classifier in thyroid nodules with indeterminate cytology","volume":"11","author":"Yang Z","year":"2022","unstructured":"Yang Z, Zhang T, Layfield L, Esebua M. Performance of Afirma gene sequencing classifier versus gene expression classifier in thyroid nodules with indeterminate cytology. J Am Soc Cytopathol. 2022, 11:74-8. 10.1016\/j.jasc.2021.07.002","journal-title":"J Am Soc Cytopathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen BR","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al.. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016, 26:1-133. 10.1089\/thy.2015.0020","journal-title":"Thyroid"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/466856-papillary-thyroid-carcinoma-in-a-patient-with-a-germline-titin-ttn-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:29:13Z","timestamp":1771759753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/466856-papillary-thyroid-carcinoma-in-a-patient-with-a-germline-titin-ttn-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.104053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,22]]}}}